LONGEVERON

Serial Number 98001693
688

Registration Progress

Application Filed
May 17, 2023
Under Examination
Feb 18, 2025
Approved for Publication
Dec 24, 2024
Published for Opposition
Dec 24, 2024
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Aug 18, 2025 33 days

Trademark Image

LONGEVERON

Basic Information

Serial Number
98001693
Filing Date
May 17, 2023
Published for Opposition
December 24, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Feb 18, 2025
Application
Pending
Classes
005

Rights Holder

Longeveron Inc.

03
Address
1209 Orange Street
Wilmington, DE 19801

Ownership History

Longeveron Inc.

Original Applicant
03
Wilmington, DE

Longeveron Inc.

Owner at Publication
03
Wilmington, DE

Legal Representation

Attorney
BRYCE J. MAYNARD

USPTO Deadlines

Next Deadline
33 days remaining
NOA E-Mailed - SOU Required
Due Date
August 18, 2025
Extension Available
Until February 18, 2026

Application History

25 events
Date Code Type Description Documents
Feb 18, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 24, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 24, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 18, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 2, 2024 EXPT T EXPARTE APPEAL TERMINATED Loading...
Dec 2, 2024 CORV 6 REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD Loading...
Dec 2, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 25, 2024 EXPI T EX PARTE APPEAL-INSTITUTED Loading...
Nov 25, 2024 EXAF T EXPARTE APPEAL RECEIVED AT TTAB Loading...
Nov 25, 2024 JURT T JURISDICTION RESTORED TO EXAMINING ATTORNEY Loading...
Nov 25, 2024 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Aug 22, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Aug 22, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
May 23, 2024 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
May 23, 2024 GNFR O FINAL REFUSAL E-MAILED Loading...
May 23, 2024 CNFR R FINAL REFUSAL WRITTEN Loading...
May 9, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 9, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 9, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 9, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 9, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 9, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 9, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 20, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 20, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Stem cells for medical or veterinary use; Pharmaceutical and veterinary preparations for the treatment of weakness, slowed motor performance, exhaustion, weight loss, decreased immune response, and increased inflammation relating to frailty in humans and animals

Classification

International Classes
005